Treatment with Tecvayli (teclistamab), an approved cancer drug, can reduce the risk of disease progression in people with high-risk smoldering multiple myeloma, an…
Myeloma
I wake up before the sun and start building the day. First the tea. Then the medication list. Then the careful arrangement of pillows…
Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma that has returned or failed…
I sit in the doctor’s office translating between two languages. The oncologist speaks in medical terms — “progression-free survival,” “bispecific antibody therapy,” “osteolytic lesions,” “minimal…
Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in an estimated 25.8 million life-years…
There are many treatments now available for multiple myeloma. Quadruplet therapy, bispecific therapy, CAR T-cell therapy, and cereblon E3 ligase modulators (CELMoDs)…
September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on blood cancer and fundraise to…
A new CAR T-cell therapy designed to target multiple myeloma while sparing healthy immune cells has been given to its first patient in a…
I hand my mum her morning tea and notice the way she adjusts her grip on the cup without saying anything. In that small movement,…
One of my very first columns asked, “Where’s my secret decoder ring?” That was because it’s easy to become overwhelmed by the many names…
Recent Posts
- As a caregiver, I’ve learned to read my mum’s daily forecast
- Short radiation course may ease painful myeloma bone lesions
- Nearly 70% of those given approved myeloma therapy alive 5 years later
- Latest AACR progress report on myeloma is a superpower of good news
- FDA green lights first-in-human study of infusion leukemia treatment